OncoHost Secures 2026 Artificial Intelligence Excellence Award in the Health Sector

Accessibility Statement [https://www.cision.com/about/accessibility/]Skip Navigation * Back to Global Sites [https://www.cision.com/home/]
* +972-77-2005042
* Blog
* Journalists
* GDPR
* Send a Release

PR Newswire: news distribution, targeting and monitoring
* News
* Products
* Contact

Hamburger menu

* PR Newswire: news distribution, targeting and monitoring
* Send a Release
* Contact
* +972-77-2005042 from 8 AM – 11 PM IL
* Contact

ONCOHOST SECURES 2026 ARTIFICIAL INTELLIGENCE EXCELLENCE AWARD IN THE HEALTH SECTOR

NEWS RELEASED BY
OncoHost [http://www.oncohost.com/] 24 Mar, 2026, 15:00 IST

SHARE THIS ARTICLE
Share toX[] Share this article

Recognition highlights organizations achieving measurable impact via artificial intelligence

BINYAMINA, Israel and CARY, N.C., March 24, 2026 – OncoHost, a precision oncology company leveraging AI to transform clinical decision-making through proteomic analysis and machine learning, has announced its selection as a winner in the 2026 Artificial Intelligence Excellence Awards, specifically in the health category. This accolade, awarded by the Business Intelligence Group, acknowledges organizations that apply artificial intelligence to create genuine, measurable outcomes.

The 2026 Artificial Intelligence Excellence Awards celebrate accomplishments across a diverse array of industries and applications, showcasing the companies and leaders propelling AI from experimental stages into actionable, accountable usage.

OncoHost garnered recognition for its PROphet® platform, a proteomics solution rooted in machine learning that decodes the biology of systemic host response to forecast immunotherapy outcomes. By merging high-dimensional plasma proteomics with explainable AI, the platform provides clinically actionable insights for newly diagnosed patients. This strategy empowers oncologists to make informed, data-driven choices, minimizes the risk of ineffective treatments, and enhances overall patient outcomes.

“The year 2026 emphasizes execution, accountability, and results,” remarked Russ Fordyce, Chief Recognition Officer at the Business Intelligence Group. “OncoHost distinguish itself as its efforts in the Health category symbolize where the market is progressing: towards practical AI that addresses tangible issues, garners trust, and delivers concrete value. This honor highlights a team that is not merely engaging in the AI transition, but actively shaping the definition of significant progress.”

“Receiving recognition from the 2026 Artificial Intelligence Excellence Awards underscores the robustness of our strategic vision and the tangible effect of our technology,” stated Ofer Sharon, MD, CEO of OncoHost. “Our aim is to redefine precision medicine by integrating clinically actionable, explainable AI into the standard oncology workflow. By elucidating the biology of host responses, we enhance treatment decision-making and establish a new standard for trust, adoption, and scalability of AI in the healthcare sector.”

OncoHost’s PROphet® platform signifies a critical leap in oncology AI, transcending traditional tumor-centric models to encompass systemic immune responses. Underpinned by the analysis of more than 7,000 proteins per patient and validated through numerous peer-reviewed publications, the platform has exhibited notable predictive efficacy in real-world clinical environments. Its adoption across about 200 U.S. cancer centers and application by hundreds of oncologists illustrates its increasing acceptance in routine clinical practices.

About OncoHost

OncoHost is a technology enterprise with headquarters in Binyamina, Israel, and Cary, North Carolina, dedicated to revolutionizing precision medicine for enhanced patient results. The company’s proprietary platform, PROphet®, functions as a plasma-based proteomic pattern analysis tool that leverages a single blood sample to inform immunotherapy decision-making. Its inaugural commercial program, PROphetNSCLC®, aids in first-line treatment determinations for metastatic non-small cell lung cancer (NSCLC) by furnishing clinically applicable insights that extend beyond tumor-only biomarkers. For further details, visit www.oncohost.com.

About the Artificial Intelligence Excellence Awards

Established in 2013, the Artificial Intelligence Excellence Awards recognize organizations, products, teams, and individuals leveraging AI technology to address real-world challenges. The program assesses advancements through 46 major AI application categories and 36 industries, honoring innovations that enhance the human experience and benefit society at large. Judged by a panel of seasoned business leaders, the awards acknowledge those committed to utilizing AI as a positive force.

About Business Intelligence Group

The Business Intelligence Group (BIG) is an independent awards organization that has acknowledged exceptional accomplishments in business since 2012. Its award programs are evaluated by seasoned business leaders and practitioners, concentrating on innovations that showcase measurable excellence and genuine impact.

Media Inquiries

Mimi Strahl – Ben Simon
Marcom Manager, OncoHost
[email protected]
+972-50-428-1138

Eliana Starbird
Chief Nominations Officer, Business Intelligence Group
[email protected]
+1 (909) 529-2737

Image – https://mma.prnewswire.com/media/2941055/AI_Excellence_Award.jpg

SOURCE OncoHost

[Link]

ADDITIONAL INFORMATION FROM THIS SOURCE

ONCOHOST PUBLISHES LANDMARK STUDY IN JPBA DEMONSTRATING SERUM-PLASMA PROTEOMIC BRIDGING, EXPANDING BIOMARKER RESEARCH CAPABILITIES. OncoHost, a technology company transforming precision oncology through proteomics and AI, recently announced the release of a significant study…
[Read more]

ONCOHOST WINS 2026 BIG INNOVATION AWARD IN HEALTH CATEGORY; NAMED A TOP 10 INNOVATOR – SMALL BUSINESS. OncoHost, a technology company redefining precision medicine for improved patient outcomes, has been named…
[Read more]

ONCOHOST WINS 2026 BIG INNOVATION AWARD IN HEALTH CATEGORY; NAMED A TOP 10 INNOVATOR – SMALL BUSINESS. OncoHost, a technology company enhancing the approach to precision medicine for superior patient outcomes, announced its recognition…
[Read more]

More Releases From This Source [news/oncohost/]